1,3-Dihydro-2,1,3-benzothiadiazol-2,2-diones and 3,4-dihydro-1H-2,1,3-benzothidiazin-2,2-diones as ligands for the NOP receptor

Bioorg Med Chem Lett. 2004 Oct 18;14(20):5045-50. doi: 10.1016/j.bmcl.2004.08.001.

Abstract

A series of 1,3-dihydro-2,1,3-benzothiadiazol-2,2-diones (I) and 3,4-dihydro-1H-2,1,3-benzothidiazin-2,2-diones (II) were prepared. While the five-member ring series (I) did not show good affinity for opioid receptors, the six-member ring series (II) exhibited extremely high affinity and selectivity for the NOP receptor and showed full agonist activity, as determined by stimulation of GTPgamma[35S] binding.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Humans
  • In Vitro Techniques
  • Ligands
  • Radioligand Assay
  • Rats
  • Receptors, Opioid, mu / agonists*
  • Receptors, Opioid, mu / metabolism
  • Structure-Activity Relationship
  • Thiazines / chemical synthesis*
  • Thiazines / chemistry
  • Thiazines / pharmacology
  • Thiazoles / chemical synthesis*
  • Thiazoles / chemistry
  • Thiazoles / pharmacology

Substances

  • Ligands
  • Receptors, Opioid, mu
  • Thiazines
  • Thiazoles